NCCN 2023 Annual Conference: Quality of Life Issues
The ASCO Post Podcast
by Harborside
1y ago
The National Comprehensive Cancer Network, or NCCN, held its annual meeting recently in Orlando. On this week’s episode of The ASCO Post podcast, we’ll hear from two presenters who discussed quality of life issues in individuals with cancer. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
Highlights From the SSO 2023 International Conference on Surgical Cancer Care
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we discuss two studies that were presented at the Society of Surgical Oncology (SSO) 2023 International Conference on Surgical Cancer Care. First, we’ll share results of the SWOGS1512 study of neoadjuvant pembrolizumab in patients with stage II to III desmoplastic melanoma. Then, we'll hear about a study which aimed to evaluate whether personalized ctDNA profiling could aid in identifying recurrence in patients with soft-tissue sarcomas. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
2023 ASCO Genitourinary Cancers Symposium: Focus on Prostate Cancer
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re continuing our coverage of data presented at the 2023 ASCO Genitourinary Cancers Symposium, which took place recently in San Francisco. We’ll hear from three researchers about their findings in prostate cancer trials reported at the meeting. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
2023 ASCO Genitourinary Cancers Symposium: Focus on RCC
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re sharing news from our coverage of data presented at the 2023 ASCO Genitourinary Cancers Symposium, which took place recently in San Francisco. We’ll hear from two researchers about their findings in renal cell carcinoma (RCC). To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
FDA Approvals: November 2022
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re reviewing U.S. Food and Drug Administration (FDA) approvals in oncology and hematology that occurred during the month of November. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
Findings From SITC 2022
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re hearing from three authors of high-impact research that was presented at the recent Annual Meeting of the Society for Immunotherapy of Cancer, or SITC. Their studies focused on immune checkpoint inhibitors for patients living with HIV and cancer, T-cell receptor T-cell therapy for patients with solid tumors, and radiation boosts plus pembrolizumab in patients with triple-negative breast cancer. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
Recent Trial Findings in Genitourinary Oncology
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re hearing from authors of recent impactful research in the field of genitourinary oncology. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
FDA Approvals in Hepatocellular Carcinoma and Multiple Myeloma
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re covering two recent approvals from the U.S. Food and Drug Administration (FDA): one in unresectable hepatocellular carcinoma, and one in relapsed or refractory multiple myeloma. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
Effects of Mortgage Discrimination on Cancer Care Outcomes
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re covering two studies that focused on the effects of mortgage discrimination on cancer care outcomes. The research—in colon and lung cancers—was presented during the 2022 ASCO Quality Care Symposium. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website
ESMO 2022: Updates in Skin Cancer
The ASCO Post Podcast
by Harborside
1y ago
On this episode, we’re highlighting speakers who presented data in skin cancers during the ESMO Congress 2022, including findings on tumor-infiltrating lymphocyte therapy in advanced melanoma, cemiplimab in cutaneous squamous cell carcinoma, and the association of circulating tumor DNA and disease recurrence in patients with later-stage melanoma. To listen to more podcasts from ASCO, visit asco.org/podcasts ..read more
Visit website

Follow The ASCO Post Podcast on FeedSpot

Continue with Google
Continue with Apple
OR